Physicians' Academy for Cardiovascular Education

HoFH: Why is early diagnosis important?

Listen to the podcast
10' education - June 29, 2022 - Prof. Kausik Ray, MD - London, UK

Video navigation menu

  • What is homozygous familial hypercholesterolemia (HoFH)? 00:51
  • Worldwise cohort study on HoFH 02:54
  • Event free survival depends upon achieved LDL-c 04:32
  • Achieved LDL-c depends upon the number of drugs used 05:13
  • Importance of earlier diagnosis and better treatment 06:35
  • LDL-c lowering strategies in HoHF 07:40
  • Concluding remarks 09:40


Show transcript

Educational information

This presentation by Prof. Ray is is the first part of a series titled "HoFH: The need to treat - creating awareness, understanding and insights".


Prof. Kausik Ray, MD, is president of the European Atherosclerosis Society, and Professor of Public Health/ Consultant Cardiologist at Imperial College London, United Kingdom.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant received from Ultragenyx.

View the slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: